Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Comera Life Sciences Holdings, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
10/10/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
10/10/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
10/06/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "12 Gill Street Suite 4650 ∙ Woburn MA 01801"
10/02/2023 8-K Quarterly results
08/24/2023 SC 13G Singer Nicholas Jason reports a 5.2% stake in Comera Life Sciences Holdings, Inc.
08/16/2023 SC 13G OTR Acquisition Sponsor LLC reports a 2.9% stake in Comera Life Sciences Holdings, Inc.
08/11/2023 ARS Form ARS - Annual Report to Security Holders:
08/11/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
08/10/2023 8-K Quarterly results
Docs: "Comera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business Highlights – Advanced to final stage of technical evaluation in Comera’s research collaboration with Regeneron, a leading U.S. biotechnology company – –Received notice that Nasdaq granted Comera’s request for the continued listing of its common stock, subject to Comera’s satisfaction of certain conditions – – Strengthened cash position with execution of a definitive agreement in July to complete a $4.1 million private placement of shares of its common stock, and accompanying warrants to purchase shares of its common stock, to existing stockholders – – Significantly expanded intellectual property portfolio, broadening both geographic coverage and claims for core SQore™ excipient technology – WOBURN, M..."
08/10/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/10/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/10/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 SC 13G IAF, LLC reports a 9.9% stake in Comera Life Sciences Holdings, Inc.
08/07/2023 D Form D - Notice of Exempt Offering of Securities:
08/07/2023 D Form D - Notice of Exempt Offering of Securities:
08/01/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
08/01/2023 8-K Quarterly results
05/19/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/19/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/19/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
05/19/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/16/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/16/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/16/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/12/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/12/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/12/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/12/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/12/2023 8-K Quarterly results
Docs: "Comera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business Highlights – Significant progress in Comera’s ongoing research collaboration with Regeneron, a leading U.S. biotechnology company – – Further development of Comera’s pipeline candidate CLS-001 , highlighted by identification of a lead formulation – – Expanded Comera’s patent portfolio, broadening geographic coverage as well as scope of claims for core SQore™ excipient technology – WOBURN, Mass., May 11, 2023 — Comera Life Sciences Holdings, Inc. , a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today reported financial results for the first quarter ended March 31, 2023, and provided a business update. “..."
05/05/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/05/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/05/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy